Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort
Colorectal Disease · 2025
DOI: 10.1111/codi.70297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2025. Verfasst von Matthew Kurien und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Occult Blood, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Aim
To evaluate long‐term colorectal cancer (CRC) incidence and faecal immunochemical test (FIT) performance in patients with low‐risk symptoms over 5 years, and to examine factors influencing outcomes and mortality.
Method
We followed 3501 symptomatic patients who underwent FIT in primary care (October–December 2019) across 225 practices in England. Building on our 18‐month study, patients were tracked for 5 years using primary and secondary care records to identify new cancers and deaths.
Results
Ten additional CRCs were diagnosed during extended follow‐up (18–60 months), beyond the 45 identified in the first 18 months. Seven of these had initial negative FIT results. FIT sensitivity at ≥10 μg/g fell from 94.1% at 18 months to 80.0% (95% CI 67.0–89.6%) at 5 years, while specificity was 80.8% (95% CI 79.4–82.1%). The positive predictive value was 6.2% (95% CI 5.4–7.2%) and the negative predictive value 99.6% (95% CI 99.3–99.8%). Patients with negative FITs experienced a significantly longer time to CRC diagnosis than those with positive FITs (median 28 vs 1 month, HR 16.4, p < 0.001). Positive FITs were also linked to higher overall cancer risk (HR 1.63, p = 0.0076) and greater 5‐year mortality (24.9% vs 11.9%, HR 2.8, p < 0.001).
Conclusion
FIT performance decreases over longer follow‐up, with 12.7% of CRCs detected after initially negative results. Positive FITs were associated with increased mortality and overall cancer risk. These findings highlight the importance of robust safety‐netting strategies for patients with negative FIT results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
- Division of Clinical Medicine, School of Medicine & Population Health, University of Sheffield, Medical School, Sheffield, UK.
ORCID-Profile: Alex John Ball
Zitieren
APA
Kurien, M., El-Siddig, M., Taylor, D. J., Elfadil, U., & Ball, A. J. (2025). Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort. Colorectal Disease. https://doi.org/10.1111/codi.70297
Vancouver
Kurien M, El-Siddig M, Taylor DJ, Elfadil U, Ball AJ. Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort. Colorectal Disease. 2025. doi:10.1111/codi.70297
BibTeX
@article{Kurien2025,
author = {Kurien, Matthew and El-Siddig, Mohamed and Taylor, Daniel James and Elfadil, Ulla and Ball, Alex John},
title = {Faecal immunochemical test demonstrates modest decline in performance characteristics but additional prognostic roles: An evaluation in a symptomatic primary care cohort},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70297}
}
EUVIMED